Sabinsa Roundtable - Curcumin C3 Reduct: first to deliver curcumin as a metabolite and only EFSA approved curcumin in the market

Over the past 30 years, Sabinsa has brought more than 100 standardised botanical extracts to market, selecting ingredients with a long history of traditional success and conducting clinical research to confirm their efficacy. Their most recent product, Curcumin C3 Complex, harnesses the unique chemical compounds of the long-revered turmeric plant – known as “curcuminoids’ – and their ability to support health and wellness.

Dr Umar Jan President of EU/UK Operations, will be leading Sabinsa’s round table, with over 10 years at Sabinsa Corporation he is one of the companies leading scientific minds and as such has been accredited to numerous Scientific papers and studies during his time here.